CreditReports.dk
HomeScreen companies

MISSIONPHARMA A/S Financials, key figures and credit report

CVR number: 26902398 Established 2002 Industry: 46 Wholesale trade
Company contact details
Vassingerødvej 9, 3540 Lynge info@missionpharma.com tel: 48163248
Net sales 933.9 mDKK FY 2025 +28% vs 2024
EBIT margin 17.0 % FY 2025 +4.3 pp vs 2024
Net debt -42.7 mDKK FY 2025 -57.7% vs 2024
Quick ratio 3.8 FY 2025 +0.8 vs 2024

Income statement (mDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales693.96924.32928.80729.80933.91
Costs of manufacturing- 398.28- 571.60- 545.38- 468.04- 534.76
External services- 173.42- 123.38- 163.46-99.33- 164.48
Gross profit122.25229.34119.75162.43234.67
Employee benefit expenses-48.34-65.44-65.69-66.65-71.42
Other operating expenses-0.70
Total depreciation-1.59-4.30-2.93-3.29-4.52
EBIT71.63159.60151.3492.48158.73
Other financial income0.213.936.004.9627.84
Other financial expenses-0.84-9.13-3.46-2.94-39.71
Net income from associates (fin.)2.67
Pre-tax profit73.67154.40153.8894.50146.86
Income taxes-15.69-35.14-34.13-21.20-26.26
Net earnings57.98119.26119.7573.30120.60

Assets (mDKK)

2021
2022
2023
2024
2025
Development expenditure1.2912.5611.45
Intangible assets total1.2912.5611.45
Land and waters22.5124.9023.8825.7424.02
Buildings1.194.826.136.375.31
Tangible assets total23.7129.7230.0132.1129.34
Participating interests33.20
Other non-current investments18.4218.2917.8415.32
Investments total33.2018.4218.2917.8415.32
Non-current loans receivable0.442.190.39
Long term receivables total0.442.190.39
Finished products/goods32.46111.48125.30124.6894.15
Inventories total32.46111.48125.30124.6894.15
Current trade debtors35.7262.2357.6660.1827.15
Current amounts owed by group member comp.262.50212.39153.4687.04175.34
Prepayments and accrued income20.6173.6122.2026.6745.16
Current other receivables9.044.566.072.683.14
Current deferred tax assets2.1912.2620.0517.3212.74
Short term receivables total330.05365.05259.45193.89263.52
Cash and bank deposits9.1025.0433.7727.5243.57
Cash and cash equivalents9.1025.0433.7727.5243.57
Balance sheet total (assets)428.52550.15470.29408.99457.35

Equity and liabilities (mDKK)

2021
2022
2023
2024
2025
Share capital2.002.102.102.102.10
Shares repurchased90.00150.00119.0073.00120.00
Other reserves35.69-2.34-2.61-3.19-5.78
Retained earnings127.1480.7081.08127.9280.83
Profit of the financial year57.98119.26119.7573.30120.60
Minority interest (BS)1.351.201.071.56
Shareholders equity total312.81351.07320.52274.21319.31
Provisions7.219.6512.0720.60
Non-current other liabilities7.219.6512.0720.60
Non-current deferred tax liabilities1.79
Non-current liabilities total1.797.219.6512.0720.60
Advances received33.92104.2876.3748.4336.46
Current trade creditors53.4256.6125.2044.3751.37
Current owed to group member0.864.690.450.89
Other non-interest bearing current liabilities25.7230.9733.8629.4628.73
Current liabilities total113.92191.87140.12122.71117.44
Balance sheet total (liabilities)428.52557.37479.95421.06477.95
Page generated